TVTX Competitors & Alternatives
Compare Travere Therapeutics Inc with similar stocks in the same industry
Biotechnology
TVTX
Main Stock$44.10
Tradestie Score
58
Market Cap
$2.21B
Revenue Growth
0.6%
Analyst Upside
+21.5%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 57 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$105.55
|
$3.98B | - | 62 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$38.31
|
$3.92B | - | 55 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$84.50
|
$3.91B | - | 55 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$20.33
|
$3.83B | - | 52 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$20.18
|
$3.68B | - | 44 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$111.39
|
$3.67B | - | 54 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$8.50
|
$3.59B | 12.5 | 49 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$22.09
|
$3.58B | 10.0 | 60 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$218.98
|
$3.49B | 28.9 | 58 | Compare |
More TVTX Analysis
Data updated: May 15, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry